2nd Annual International Cannabinoid Derived Pharmaceuticals Summit

Start:
Sep 10, 2019, 9:00 AM
End:
Sep 12, 2019, 6:00 PM

About 2nd Annual International Cannabinoid Derived Pharmaceuticals Summit

Following the success of the first iCDP summit last year, we are returning this September to provide the primary industry platform for the advancement of cannabinoid-derived pharmaceuticals. When this summit takes place it will have been just over a year since GW Pharmaceutical’s created the first FDA approved drug containing a cannabinoid API, and several contenders are hot on their heels. However, there are many challenges still obstructing the development of this generation of cannabinoid pharmaceuticals.
Join your peers at the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit to solve your challenges in this fast growing field, and to maximise the potential of the next-generation of cannabinoid pharmaceuticals.

Speakers

Guy Chamberland
Chief Executive Officer Tetra Biopharma
Dennis Ahern
Vice President, Global Regulatory Affairs, Greenwich Biosciences
MARA GORDON
Founder & Director Zelda Therapeutics Limited
Dominic Chiapperino
Director, Controlled Substance Staff
Brian Murphy
CEO, Emerald Bioscience
Sara Ward
Researcher Oncology Temple University
View More (2)
Dr. Andrea Small-Howard
Chief Science Officer GB Sciences Inc

Partners

VerdeMed
CBDepot
Avicanna
Medical Cannabis and Cannabinoids
Noramco